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Chronic traumatic encephalopathy (CTE) is a progressive neurodegenerative disease that is a long-term consequence of single or
repetitive closed head injuries for which there is no treatment and no deﬁnitive pre-mortem diagnosis. It has been closely tied to
athletes who participate in contact sports like boxing, American football, soccer, professional wrestling and hockey. Risk factors
include head trauma, presence of ApoE3 or ApoE4 allele, military service, and old age. It is histologically identiﬁed by the presence
oftau-immunoreactiveNFTsandNTswithsomecaseshavingaTDP-43proteinopathyorbeta-amyloidplaques.Ithasaninsidious
clinicalpresentationthatbeginswithcognitiveandemotionaldisturbancesandcanprogresstoParkinsoniansymptoms.Theexact
mechanism for CTE has not been precisely deﬁned however, research suggest it is due to an ongoing metabolic and immunologic
cascade called immunoexcitiotoxicity. Prevention and education are currently the most compelling way to combat CTE and will
be an emphasis of both physicians and athletes. Further research is needed to aid in pre-mortem diagnosis, therapies, and support
for individuals and their families living with CTE.
1.Introduction
Chronic traumatic encephalopathy (CTE) has been deﬁned
as a progressive neurodegenerative disease caused by repeti-
tive head trauma [1]. CTE was ﬁrst described in 1928 when
Dr. Harrison Martland, a New Jersey medical examiner,
began to note a constellation of symptoms in boxers. In an
article he published in the Journal of the American Medical
Association entitled Punch Drunk, he describes the boxers,
“cuckoo,” “goofy,” “cutting paper dolls,” or “slug nutty”
[2]. Punch drunk was later termed dementia pugilistica,
literally meaning dementia of a ﬁghter. However, with the
evolution of sports like American football, these symptoms
were also being reported in athletes other than boxers
and was renamed chronic traumatic encephalopathy in the
1960s.
CTE has become a popular topic due to its close
association with American football, hockey, soccer, boxing,
and professional wrestling. Many of these aﬀected athletes,
mostly retired, have struggled in their later years with
depression, substance abuse, anger, memory/motor distur-
bances, and suicide [3]. Autopsy results from these athletes
have suggested a link between these emotional, cognitive,
and physical manifestations and CTE [3–5]. In addition to
athletes, military soldiers have become another group of
interest as many are returning from the battleﬁeld with brain
injuries from blast trauma causing closed head injury. In
this paper we present a summary of the epidemiology, risk
factors, clinical presentation, pathophysiology, neuropatho-
logical ﬁndings, treatment/prevention, and future research
pertaining to CTE.
2. Epidemiology
Concussion or mild traumatic brain injury (mTBI) is one
of the most common neurologic disorders accounting for
approximately 90% of all brain injuries sustained [4]. Such
injuries are a common occurrence in athletes with an esti-
mated 1.6–3.8 million sport-related concussion annually in
the USA [5]. This can be seen as a gross underrepresentation
of the true number as many athletes do not seek medical
attention or vocalize their symptoms. This may be due to
head trauma being regarded as benign, or in some the injury2 Rehabilitation Research and Practice
is not recognized at all. These behaviors are driven by the
athletes’ desire to return to play and the pressure to perform
[6]. DeKosky et al. reported that each year more than 1.5
million Americans have mTBI with no loss of consciousness
and no need for hospitalization as well as an equal number
with conscious impairing trauma but insuﬃciently severe to
require long-term hospitalization [7].
In a 2009 review of CTE, McKee et al. found that of
51 neuropathologically diagnosed cases of CTE 46 (90%)
occurred in athletes. Speciﬁcally, athletes participating in
American football, boxing, soccer, and hockey comprise
the majority of cases. Many of these athletes began their
respective sports at a young age between 11 and 19 years
[5]. While it is not clear at what age CTE can begin,
McKee has neuropathologically diagnosed CTE changes in
asymptomatic 18-year-old high school football player with
a history of concussion. While the exact incidence of CTE
is unknown, it is thought to vary widely based on sport,
position,lengthofcareer,numberofheadinjuries,ageofﬁrst
head injury, and genetics [8].
3. Risk Factors
It has been well established that repetitive concussive or
subconcussive blows to the head place individuals at risk
for CTE [5, 6, 8]. CTE has been associated with athletes
who participate in contact sports like American football,
boxing, hockey, soccer, and professional wrestling. Other
sports that are not directly associated with CTE, but have
well-documented cases of concussion, include mixed martial
arts, rugby, and horseback riding. Other groups at risk
for repetitive head trauma and CTE are military veterans,
epileptics, and victims of domestic abuse [5]. It has been
reported that approximately 17% of professional retired
boxers will exhibit CTE [3]. Although each group listed has
a unifying factor of head trauma, they diﬀer in particular
aspects that may inﬂuence the severity or chronicity of their
injury (see Table 1 for a summary of risk factors).
A recent study by Crisco et al. examined head impact
exposure in collegiate football players and found that the
average number of impacts received by an individual player
during a single season was 420 with a maximum of 2,492
[9]. These impacts vary in severity based on their position.
Oﬀensive linemen, defensive linemen, and linebackers had
the most frequent impacts while quarterbacks and running
backs received the greatest magnitude of head impacts [9].
In the literature McKee and colleagues reported that in
ﬁve football players with diagnosed CTE all played similar
positions: 3 were oﬀensive linemen, 1 defensive linemen,
and one linebacker [5]. However, according to Boston
University’s Center for the Study of Chronic Traumatic
Encephalopathy, CTE has also been found in other position
players like safety and wide receiver dismissing the idea that
only certain positions are at risk for developing CTE.
While it is clear that anyone who suﬀers repeated head
trauma, regardless of the mechanism, may carry the risk of
developing CTE, there is no clear consensus on how much
or how little trauma is needed to cause CTE. While most feel
Table 1: Risk factors associated with chronic traumatic enceph-
alopathy.
(i) Head trauma: single or repetitive
(ii) History of head concussion
(iii) Participation in the following
Boxing
American football: oﬀensive/defensive
linemen/linebackers/running backs
Soccer
Professional wrestling
Hockey
Military service: blast injuries
(iv) Length of sport participation
(v) Epileptics
(vi) Victims of domestic abuse
(vii) Age of injuries: younger ages and older ages
(viii) Genetic variation: ApoE3 or ApoE4
CTE is a manifestation of repetitive trauma, the question still
stands if it can be caused by a single TBI [10]. In a study by
Johnson et al., widespread tau and beta-amyloid deposition
was found in the brains of individuals who suﬀered a single
traumatic brain injury. The study included the examination
of postmortem brains from long-term survivors (1–47 years)
of a single TBI (N = 39) versus uninjured age-matched
controls (N = 47). Results showed NFTs to be exceptionally
rare in young uninjured controls, yet were abundant and
diﬀuse in one-third of TBI cases. This was also true of
beta-amyloid deposition, which was found in greater density
following TBI than controls [11]. While these brains showed
classic changes associated with CTE, they did not have the
symptomatic proﬁle to accompany their neuropathologic
ﬁndings [11]. If these subjects went on to have repeated
brain injury, it would be reasonable to expect more extensive
damage with more pronounced clinical symptoms.
In a study of repeated head trauma in mice, Kane et al.
created an animal model where mice did not suﬀer severe
TBI but rather mTBI to look for CTE-like changes. They
reportedthatexposuretoheadtraumafor5consecutivedays
showed increased expression of glial ﬁbrillary acidic protein
and phospho-tau 30 days (∼160% increase) after the last
injury when compared to controls. They also reported that
with their mTBI model they did not ﬁnd edema, cortical
contusions, obvious loss of neuronal matter beneath the
skull, disruption of the blood brain barrier, or microglial
activation. However, they compared this to mice that were
subject to a single traumatic injury and found substantial
microglial activation in the hippocampus and overlying
cortex 30 days after the initial impact [12].
Another high-risk group that has recently been studied
are individuals in the military [12]. Operations in Iraq and
Afghanistan are reporting that TBI accounts for roughly
28% of all combat casualties and approximately 88% of
these are closed-head injuries [12]. While these numbers
are signiﬁcant, the US Defense and Veterans Brain InjuryRehabilitation Research and Practice 3
Center has estimated that approximately 180,000 soldiers
have been diagnosed with mTBI between 2001 and 2010
while others estimate the number to be more than 300,000.
Additionally, soldiers may also be exposed to toxins like
organophosphates, chemical nerve agents, and heavy metals
like uranium increasing their risk for brain injury [13].
Age is another possible risk factor for the development
of CTE. At younger ages, while the brain is developing
traumatic injury may begin the cascade of destructive events
and compounded through the years of continued play.
Conversely, at younger ages the brain has more plasticity
allowing greater ability to manage injury than that in the
mature brain [8, 10]. Length of play is another risk factor
where longer careers with prolonged exposures to injury
may cause more severe CTE. Of the 51 cases reviewed by
Dr. McKee, 39 boxers had an average career of 14.4 years
(range 4–25) while the 5 football players averaged careers
of 18.4 years (range 14–23 years). These athletes began their
respective sports between 11 and 19 years of age [5].
Genetic factors have also been thought to play a role
in the development of CTE speciﬁcally the apolipoprotein
E gene (ApoE). The ApoE4 allele has been well described
in its association with Alzheimer’s disease (AD) where
individuals with homozygous ApoE4/E4 genotype have a 19-
fold increased risk of developing AD [14]. This same gene
is now thought to possibly have a role in the development of
CTE[5].StudieshaveshownthatApoE4-positiveindividuals
had poorer outcomes with head trauma. Teasdale et al.
reported that that patients with ApoE4 allele are more than
twice as likely than those without ApoE4 to have unfavorable
outcomes 6 months after head injury [15]. Kutner et al.
examined 53 professional American football players to see if
their cognitive functioning diﬀered based on age and ApoE4
genotype. They reported that older age and presence of
ApoE4scoredloweroncognitiveteststhandidthosewithout
the allele or with less playing experience [16]. Jordan et al.
looked at ApoE4 genotype in boxers in relation to chronic
TBI. They found that all boxers with severe impairment,
based on the chronic brain injury scale, had at least 1 ApoE4
allele.Therefore,theyreportedthatApoE4maybeassociated
withincreasedseverityofchronicneurologicdeﬁcitsinhigh-
exposure boxers [17].
In McKee and colleagues’ review of the 51 CTE cases,
ApoEgenotypingwasreportedin10caseswhere50%carried
at least one ApoE4 allele and one was homozygous for E4.
While they did not report what the other 4 genotypes were, it
raised their suspicions to believe that ApoE4 was the gene
of interest. In animal studies ApoE4 transgenic mice had
greater mortality from TBI than those with ApoE3 allele.
Another study showed that transgenic mice that overexpress
ApoE4 allele showed increased deposition of beta-amyloid
after experimental TBI [5].
However, a study by Omalu et al. reported that 70% of
their CTE cohort had the ApoE3 genotype. Of the 17 athletes
theyusedintheirstudytheywereabletodeterminetheApoE
genotype in 10 of 14 professional athletes and in 2 of 3 high
school athletes. Of the 10 professional athletes 90% had at
least one ApoE3 allele, and 7 of the 10 with conﬁrmed ApoE
genotype also had CTE. Of these 7 athletes with CTE 100%
had at least one ApoE3 allele (5 E3/E3, 2 E3/E4). It should
also be noted that the only professional athlete in their study
that did not have the E3 allele (E2/E4) was negative for CTE.
Additionally, the two other professional athletes that had the
ApoE allele but did not have CTE were E2/E3 (24 years old)
and E3/E3. The authors note that the one case of E3/E3 that
didnothavetauopathywasassessedfromonlyselectsections
of the brain as they did not have access to the full brain. Of
the two high school athletes both were E3/E3 genotypes and
did not show any histological signs of CTE [18].
4. ClinicalPresentation
It is important to deﬁne the timeline of CTE symptom
development to distinguish it from concussive or postcon-
cussive syndrome (PCS). The symptoms associated with
acute concussion are headache, blurred vision, amnesia,
tinnitus, fatigue, and slurred speech with resolution within
days to weeks if managed properly. Although there is no
strict timeline to the acute injury phase, it has typically
been reported as three months, but 80–90% of patients
show full recovery within the ﬁrst 10 days [19]. When
symptoms extend beyond three months, the individual is
said to have PCS. These individuals will have additional
symptoms of physical, emotional, cognitive, and behavioral
problems [6]. PCS also has a variable timeline where
symptoms typically improve within one year but may in
somecasesrequireseveralyearsforresolution.Forthosewith
persistingorpermanentPCSsymptoms,theywouldlogically
be considered to have CTE.
However, the typical clinical course of an individual who
develops CTE is not as linear as direct progression from
concussion to PCS to CTE. The onset of CTE symptoms
typically starts later in the lives of certain athletes after the
individual has removed themselves from competition. As
reported by McKee, the ﬁrst symptoms of CTE were noted
at ages ranging from 25 to 76 years. McKee also reported
that at the time of retirement one-third of these athletes
were symptomatic with another half becoming symptomatic
within 4 years of leaving sports [5]. In 14 cases (30%), mood
disturbances were reported while movement abnormalities
likeParkinsonism,ataxia,antalgicgait,anddysarthricspeech
werereportedin41%of subjects[5].Thecourseofsymptom
progression seems to follow a somewhat continuous path
beginning with cognitive and emotional decline leading to
eventual motor deterioration [5].
Initially, patients begin to have poor concentration,
attention, and memory along with disorientation, dizzi-
ness, and headaches. They typically progress to experience
irritability, outbursts of violent or aggressive behavior,
confusion, and speech abnormalities. During this stage of
the disease, there is a high frequency of suicide, drug
overdose, and mood disorders, mainly major depressive
disorder [5]. A study by Omalu and colleagues describes a
similar clinical proﬁle with a latent asymptomatic period
between play and symptom onset. He reports worsening
of cognitive and social functioning leading to poor money
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insomnia, poor relationships, divorce, emotional/physical
abuse, and substance abuse [18]. Family and friends of
the aﬀected individuals reported many of these symp-
toms to researchers through standard forensic interviews
[18].
As the disease progresses in severity, there is a greater
loss of motor functioning. Some patients may develop
Parkinsonian symptoms of tremors, masked facieses, wide
propulsive gait, poor speech, ocular abnormalities, vertigo,
bradykinesia,deafness,andasmallgroupdevelopingdemen-
tia. Currently, the number of cases with conﬁrmed dementia
remainssmall.Asmorepostmortemexamsaredoneintheat
risk group, it is expected more cases will be diagnosed. Some
individuals with CTE have committed suicide, overdosed on
drugs, or died from accidents preventing progression of the
disease [5, 20].
5.Pathophysiology
The development of CTE is due to repetitive traumatic brain
injury from the acceleration/deceleration forces of closed
headimpacts[5].Damagetothebraingenerallyoccurswhen
the brain collides against the skull causing damage to the
same side as the collision, coup, or to the opposite side
of the impact, countercoup [6]. High-speed decelerations
may also cause mechanical and chemical injury to the long
axons resulting in traumatic/diﬀuse axonal injury. Crisco
et al. report that impacts to the top of the head had the
lowest rotational force but highest linear force leading more
to cervical spine injuries. However, lateral blows cause rota-
tional forces, which are the typical cause of mild traumatic
brain injury [6]. While there is a ﬁrm understanding of head
trauma being the general cause of the brain damage in CTE,
researchers have not agreed upon a unifying mechanism of
injury. Originally the associated axonal damage was thought
to be due to shearing or mechanical forces at the time of
injury. However, it is now reported that axonal shearing or
tearing is a secondary event to the acute inﬂammation and
neurodegeneration of axons [5]. In the acute setting there is
rapid axonal swelling, perisomatic axotomy, and Wallerian
degeneration [5].
Gavett et al. oﬀered a general description of how the
damage may occur through the repeated traumatic injury of
axons. Damage to axons would cause changes in membrane
permeability and ionic shifts causing a large inﬂux of
calcium. Subsequent release of caspases and calpains would
trigger tau phosphorylation, misfolding, shortening, and
aggregation as well as cytoskeleton failure with dissolution
of neuroﬁlaments and microtubules [8].
This idea was elaborated on in a recent paper by Blaylock
and Maroon who describes the concept of immunoexci-
totoxicity as a possible central mechanism for CTE. He
describes a cascade of events that begin with an initial
head trauma, which “primes” the microglia for subsequent
injuries. When the homeostasis of the brain is disturbed,
some of the microglia undergo changes to set them in
a partially activated state. When these microglia become
fully activated by continued head trauma, they release toxic
levels of cytokines, chemokines, immune mediators, and
excitotoxins like glutamate, aspartate, and quinolinic acid.
These excitotoxins inhibit phosphatases, which results in
hyperphosphorylated tau and eventually neurotubule dys-
function and neuroﬁbrillary tangle deposition in particular
areas of the brain [10]. There is also an apparent syn-
ergy between the proinﬂammatory cytokines and glutamate
receptors that worsen neurodegeneration in injured brain
tissue. This combination also increases the reactive oxygen
and nitrogen intermediates that interfere with glutamate
clearance keeping the injury response high. Priming can
also occur from insults to the brain like systemic infec-
tions, environmental toxins, and latent viral infections
in the brain (cytomegalovirus and herpes simplex virus)
[10].
The microglia, however, have a dual function allow-
ing them to switch between being neurodestructive and
neuroreparative. During acute injury the microglia are
responsible for containing the damage with inﬂammation,
cleaning up debris, and repairing the surrounding damaged
tissue [10]. However, if the individual experiences a second
brain trauma or multiple continuous traumas, the microglia
may never have the chance to switch from proinﬂammatory
to reparative mode [10]. Such repetitive trauma may place
the brain in a state of continuous hyperreactivity leading
to progressive and prolonged neuronal injury. This would
support the evidence that repeated mTBI results in a higher
incidence of prolonged neurological damage than single-
event injury [10].
The eventual neurodegeneration is also dependent on
other factors like the age of the brain at the time of injury.
Severalstudieshaveshownthatolderindividualshavepoorer
outcomes when compared to younger subjects experiencing
TBI. Streit et al. showed that as the microglia age, they
become more dysfunctional, which may impair their ability
to terminate immune activation. Therefore, as the brain
grows older, it has more activation of microglia with weaker
mitochondrial functioning, neuronal and glial dystrophy,
higher levels of inﬂammation, and lifetime exposures to
environmental toxins [10].
6.GrossPathology Findings
As described by Corsellis et al., the most common gross
pathological ﬁndings in CTE included reduced brain weight,
enlargement of the lateral and third ventricles, thinning
of the corpus callosum, cavum septum peallucidum with
fenestrations, scarring, and neuronal loss of the cerebellar
tonsils. Brain atrophy was most severe in the frontal
lobes (36%), temporal lobes (31%), and parietal lobes
(22%) with the occipital lobe rarely being aﬀected [5].
McKee and colleagues reported that with increasing severity
of disease marked atrophy is noted in the hippocam-
pus, entorhinal cortex, and the amygdala [5]. Blaylock
and Maroon reported that these areas showed the most
severe atrophy and were noted to have the highest con-
centration of glutamate receptors and cytokine receptors
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7.Microscopic Pathology
According to Dr. Bennet Omalu, a forensic neuropathol-
ogist, the basic feature of CTE is the presence of sparse,
moderate, or frequent band-shaped, ﬂame-shaped small
globose and large globose neuroﬁbrillary tangles (NFTs) in
the brain accompanied by sparse, moderate, or frequent
neuropil threads (NTs) [18]. Similarly, McKee and colleagues
described the core pathology of CTE to include tau-reactive
NFTs, astrocytic tangles, and dot-like spindle-shaped NTs
[10]. These changes are commonly noted in the dorsolateral
frontal, subcallosal, insular, temporal, dorsolateral parietal,
and inferior occipital cortices. Additionally, Dr. McKee also
reported occasional tau immunoreactive neuritis and NFTs
in the posterior, lateral, and/or anterior horns of the spinal
cord (see Table 2)[ 10].
Beta-amyloid (Aβ) deposition is an inconsistent ﬁnding
in CTE as Dr. McKee noted that of the 51 cases of conﬁrmed
CTE she reviewed that only 3 (6%) had amyloid angiopathy
[5]. Animal studies by Iwata et al. used swine TBI models to
show minimal Aβ accumulation in axons acutely after injury
but saw greater accumulation one month following injury
[20]. Similarly Chen et al., also using a swine TBI model,
found evidence of axonal pathology 6 months following
rotational brain injuries [21].
Although CTE and Alzheimer’s disease (AD) both have
NFTs and possibly beta-amyloid plaques, there are several
unique features that distinguish the two [8]. First, beta-
amyloid deposits are only found in 40% to 45% of patients
with CTE while they are present in nearly all cases of AD.
Secondly, the tau distribution in CTE is located more in the
superﬁcial cortical laminae whereas in AD they are found in
large projection neurons in deeper layers. It is also important
to note is the distribution of the NFTs in CTE that extremely
irregular with uneven foci in the frontal temporal and
insular cortices, while AD has a more uniform cortical NFT
distribution. DeKosky et al. noted that the hippocampus is
frequently spared by tauopathy in CTE, whereas it is the ﬁrst
locationaﬀectedbytauopathyinAD[7].Lastly,NFTsinCTE
are most concentrated at the depths of the cortical sulci and
are typically perivascular, which might indicate that there are
disruptionsofcerebralmicrovasculatureandtheblood-brain
barrier at the time of injury leading to NFT formation [8].
A recent study by Omalu et al. described four his-
tomorphologic phenotypes of CTE in American athletes
(see Table 3). They examined specimens from 17 deceased
athletes,10ofwhichhadhistopathologicallyconﬁrmedCTE.
All were male, age range of 17–52, (8 were American football
players, 4 professional wrestlers, 1 mixed martial arts ﬁghter,
1 professional boxer, and 3 high school American football
players). Omalu and colleagues created these histologic
phenotypes based on the presences or absence of NFTs, NTs,
and diﬀuse amyloid plaques as well as their quantitative
distribution in the cerebral cortex, subcortical nuclei/basal
ganglia, hippocampus, and cerebellum. These results are
s u m m a r i z e di nT a b l e s1 and 2. Phenotype one shows
sparse to frequent NFT and NTs in the cerebral cortex and
brainstem without involvement of the subcortical nuclei,
basal ganglia, or cerebellum without any beta-amyloid.
Table 2: Areas of damage in the brain.
Gross areas of damage
(i) Reduced brain weight with atrophy of
Frontal lobe
Temporal lobe
Parietal lobe
Occipital lobe
(ii) Enlargement of lateral and third ventricles
(iii) Thinning of the corpus callosum
(iv) Cavum septum pellucidum with fenestrations
(v) Scarring and neuronal loss of cerebellar tonsils
(vi) Pallor of substantia nigra
Areas of tau NFTs and NT
(i) Superﬁcial cortical layers
(ii) Dorsolateral frontal
(iii) Subcallosal
(iv) Insular
(v) Temporal
(vi) Dorsolateral parietal
(vii) Inferior occipital cortices
(viii) Thalamus
(ix) Hypothalamus
(x) Substantia nigra
(xi) Olfactory bulbs
(xii) Hippocampus
(xiii) Entorhinal cortex
(xiv) Amygdala
(xv) Brainstem
Phenotype two is the same as the ﬁrst except they show
diﬀuse beta-amyloid plaques. The third group had higher
concentrations of NFTs and NTs only in the brainstem
without involvement elsewhere with no beta-amyloid. The
fourthgrouphadsparseNFTsandNTsinthecerebralcortex,
brainstem, subcortical nuclei, and basal ganglia with an
unaﬀected cerebellum and no beta-amyloid [18].
Trans-activator regulatory DNA-binding protein 43 or
TDP-43 has been a recent addition to the growing neu-
ropathologic ﬁndings associated with CTE. TDP-43 is a
highly conserved protein that is found in many tissues
including the CNS [22]. It plays a signiﬁcant role in
mediating the response of the neuronal cytoskeleton to
axonal injury [8]. In a study by McKee et al., they reported
widespread TDP-43 proteinopathy in 80% of their CTE
cases. Until this study, TDP-43 was thought to be a
unique ﬁnding to amyotrophic lateral sclerosis (ALS) and
frontotemporal lobar degeneration (FTLD-TDP) but has
now been found in other neurodegenerative diseases as a
secondary pathology [22].6 Rehabilitation Research and Practice
Table 3: Emerging histomorphologic phenotypes in American athletes.
Phenotype Histological ﬁndings
1 Sparse to frequent NFT and NTs in the cerebral cortex and brainstem without involvement of the subcortical nuclei, basal
ganglia, or cerebellum without any beta-amyloid
2 Sparse to frequent NFT and NTs in the cerebral cortex and brainstem with diﬀuse beta-amyloid deposition. No
involvement of the subcortical nuclei, basal ganglia, or cerebellum
3 Higher concentrations of NFTs and NTs only in the brainstem. No involvement elsewhere or any beta-amyloid
4 Sparse NFTs and NTs in the cerebral cortex, brainstem, subcortical nuclei, and basal ganglia with an unaﬀected cerebellum
and no beta-amyloid [18]
8. Clinicopathologic Correlations
The typical symptoms of CTE can be directly connected
to the speciﬁc areas of the brain that are injured during
the progression of disease. Based on these symptoms it
is clear that there is damage to the hippocampal-septo-
hypothalamic-mesencephalic circuitry (Papez circuit) also
known as the emotional or visceral brain [5]. Damage
to these areas correlate to the behavioral symptoms of
emotional liability, aggression, and violence. Damage to
the hippocampus, enteorhinal cortex, and medial thalamus
conceivably causes the commonly reported complaint of
memory disturbance. Destruction to the frontal cortex and
white matter may result in the dysexecutive symptoms found
throughout the many cases of CTE. Motor abnormalities
may be due to degeneration of the substantia nigra and pars
compacta along with symptoms of dysarthria, dysphagia,
and ocular malfunction due to brainstem nuclei injury like
the hypoglossal and oculomotor nuclei (see Table 4)[ 5].
9.NeurologicalSequelae
Historically amyotrophic lateral sclerosis (ALS) has been
thought to be a sporadic disease with no single causative
factor. Literature has reported risk factors to include trauma
to the brain or spinal cord, strenuous physical activity,
exposure to heavy metals, cigarette smoking, radiation,
electricalshocks,andpesticides[22].Giventheseriskfactors,
the literature strongly correlates a history of head trauma
with increased incidence of ALS. In a case control study,
Chenetal.reportedthathavingrepeatedheadtraumawithin
the 10 years prior to diagnosis had a 3-fold higher risk of
ALS [23]. The same group also did a meta-analysis of 8
ALS studies and estimated a pooled odds ratio of 1.7 (95%
CI: 1.3, 2.2) for at least one previous head injury. Another
study reported increased ALS incidence and mortality in
professional Italian soccer players when compared to the
general population [24]. Additionally, an incidence study
of 7,325 Italian professional soccer players showed an ALS
incidence 6.5 times higher than expected [25]. ALS has also
beenseeninhighernumbersamongAmericanandCanadian
football players when compared to the general population
[22]. The risk of ALS has also been reportedly high in war
veterans. A study of Gulf War veterans reported that the risk
of ALS was increased 2-fold during the 10 years following
service [26]. A study by Schmidt et al. reported that veterans
who received head trauma during war had an adjusted odds
ratioforthedevelopmentofALSof2.33(95%CI:1.18–4.61)
[27].
A recent study by McKee and colleagues examined and
compared the brains and spinal cords of 12 athletes with
conﬁrmedCTEto12casesofsporadicALSto12-agematched
controls. Of the 12 CTE cases, 3 also had a diagnosed
motor neuron disease (MND) resembling ALS. The study
found that those with CTE and the motor neuron disease
not only had the typical neuropathologic presentation of
CTE with tau-NFT, NT, and TDP-43 throughout the brain
and brain stem, but they also had these changes in the
anterior horns of the spinal cord in high concentrations.
Of the 9 CTE patients that did not have the MND, they
had similar CTE neuropathology, but it did not aﬀect the
spinal cord as signiﬁcantly. When compared to the samples
of sporadic ALS, they found TDP-43 immunoreactivity in
all 12 cases with no tau immunoreactive NFTs. The age-
matched controls showed no TDP-43 or tau reactivity. These
results indicate that the widespread tauopathy and TDP-
43 proteinopathy of CTE can in some cases extend beyond
the brain and the brain stem to severely aﬀect the spinal
cord. The authors have labeled these cases as having chronic
traumatic encephalomyelopathy (CTEM). While this has
only been identiﬁed in three cases, it opens the ﬂoor to
further discussion and research to see if CTEM is in fact a
uniquediseaseorjustthecoincidentaloccurrenceofALSand
CTE. McKee has stated that the tau pathology in the three
casesofCTEMisnotonlydistinctfromthatofsporadicALS,
but the nature and distribution of the TDP-43 proteinopathy
are also unique [22].
10.Diagnosis
Currently the only way to deﬁnitively diagnose CTE is
throughpostmortemneuropathologicalautopsy[8].Clinical
diagnosis is diﬃcult due to a lack of consensus on diagnostic
criteria or large-scale longitudinal clinicopathologic correla-
tion studies [8]. The diﬀerential diagnosis for CTE usually
includes diseases like AD and frontotemporal dementia
(FTD),whichallsharesimilarclinicalsymptoms,andallmay
have a history of head trauma making a clinical diagnosis
diﬃcult. Although age can help in distinguishing between
AD and CTE, it does not help when deciding between FTD
and CTE.
It is the hope of many that the advances in neuroimaging
will aid in detecting chronic and acute changes associated
withCTE.Diﬀusion tensor imaging (DTI) has been reportedRehabilitation Research and Practice 7
Table 4: Clinicopathological correlations [5].
Damage area Clinical presentation
Hippocampus
Entorhinal cortex
Medial thalamus
Early deﬁcits in memory
Frontal cortex and underlying
white matter Dysexecutive symptoms
Dorsolateral parietal
Posterior temporal
Occipital cortices
Visuospatial diﬃculties
Substantia nigra
Pars compacta
Parkinsonian motor
features
Cortical and subcortical frontal
damage
Cerebellar tract injury in
brainstem
Gait disorder: staggered,
slowed, ataxic
Brainstem nuclei
(hypoglossal/oculomotor)
Dysarthria, dysphagia,
ocular abnormalities
Amygdala Aggression and violent
outbursts
to be sensitive enough to assess axonal integrity in the
setting of mild, moderate, and severe TBI. DTI studies have
shown their ability to show occult white matter damage
after mTBI that was not visible on typical MRI scans. A
study by Kumar et al. tracked serial changes in white matter
using DTI techniques in mTBI and found that fractional
anisotropy (FA) and mean diﬀusivity (MD) in the genu of
the corpus callosum appear early and persisted at 6 months
as a secondary injury to microgliosis [28]. Another study by
Inglese et al. showed the abilities of DTI as they reported
signiﬁcant abnormalities in various regions of the brain after
mTBI when compared to controls [29]. A third study by
Henry and colleagues used DTI to detect changes in white
matter by comparing a group of 10 nonconcussed athletes to
18concussedathletes.Theyreportedthatat1–6daysandat6
months following concussion there was FA in dorsal regions
of both cortical spinal tracts and the corpus callosum [30].
Although researchers are trying to identify biomarkers to
aid in diagnosis, there currently are no makers identiﬁed in
the literature that can be used to diagnosis CTE. However,
there are several that are believed to help in identifying CTE
like the use of magnetic resonance spectroscopy that can
detect changes in glutamate/glutamine, N-acetyl aspartate,
and mylo-inositol which have been shown to be abnormal in
braininjury[8].Therehasalsobeendiscussionofattempting
to measure tau and phospho-tau in the cerebrospinal ﬂuid of
those suspected of having CTE [8].
11.Treatments/Prevention
Currently, the treatment methodologies for CTE are purely
preventive. However, in sports like American football, pre-
vention of head trauma is a seemingly diﬃcult goal to attain.
Hard hits and head collisions are more than simple aspects
of the game; they are part of the sports identity. Therefore,
prevention would require a multifaceted approach involving
administrators, coaches, players, referees, team physicians,
and even the fans who watch the games. The administrators
create the policies that penalize athletes for reckless or
dangerous hits as well as setting equipment standards for
the various leagues. It is the role of the coaches to teach
their players correct and safe technique for tackling, hitting,
and personal protection while creating a team culture that
encourages hard but controlled play. Coaches also need to be
aware of the cumulative eﬀect of repetitive mTBI and limit
the amount of full contact during practice and drills. It is the
role of the players to understand the potential dangers and
consequences of head trauma beyond their playing years so
they can protect themselves and limit the number of injuries
during their career. It is also incumbent on the athlete to
not downplay their injuries and to seek help or advice if
they are suﬀering from signs or symptoms of head trauma.
As for the referees, it is their role to create a safe playing
environment and uphold the rules set forth to protect the
players whether on the ﬁeld, in the ring, or on the ice. As
for the team physician, it is their task to remove players
from play and appropriately manage their mTBI until they
meet the return-to-play criteria. The decision to clear a
player is challenging for the physician who has no baseline
information of the player’s cognitive function prior to the
injury. Therefore, it has been suggested that players undergo
neuropsychological testing prior to participation in sports as
a tool to properly assess the athlete’s cognitive deﬁcits both
acutely and chronically.
Another aspect of prevention is improving the protective
equipment worn by the athletes. It has been shown that
helmets and mouth guards function very well in protecting
the player from severe head injury if the helmet ﬁts correctly,
is strapped in place, and lined with the appropriate padding
[6]. A study by Viano and Halstead compared American
football helmets from 1970 to 2010 and reported that the
newer helmets are heavier, primarily from more padding,
longer, higher, and wider then their 1970s counterparts.
These larger helmets were better at absorbing forces and
impacts associated with concussions in American football
[31]. While helmets are important, they may also give some
players a false sense of protection leading to a more reckless
and violent style of play. Neck strength is another factor that
can be important in minimizing head injury especially in
younger populations of athletes and should be emphasized
by trainers and strength coaches [6]. Some groups are
looking for medical therapies to limit the damage after a
head injury. Particularly, the use of beta-amyloid-lowering
medications has been shown to improve the outcomes
following TBI in rodent models [7].
12. FutureConsiderations for Research
Although there has been an exponential growth in research
and interest in CTE over the last ﬁve years, the full under-
standing of it still remains in its infancy. Aﬀected athletes
have been the greatest supporters as Boston University’s
Center for the Study of CTE has more than 260 former
athletes in their brain and spinal cord donation registry.8 Rehabilitation Research and Practice
These donations will supply researchers with a wealth of
information that will improve animal models, better deﬁne
the mechanism of injury, as well as advance diagnosis and
treatment. As the foundation of knowledge grows, we can
better identify genetic variants that put individuals at risk for
CTE. The CTE community will also beneﬁt from ongoing
concussion research as groups look for acute biomarkers to
be used as a diagnostic test for brain injury. There is also
a need for further research regarding the role of advanced
neuroimaging like DTI and its ability to possibly detect early
signs of acute injury. Additionally, more work must be done
toquantifythemagnitudeandfrequencyofheadimpactthat
is needed to cause the neurodegeneration associated with
CTE.
13. Conclusions
Chronic traumatic encephalopathy is a neurodegenerative
disease that is a long-term consequence of single or repetitive
closed head injuries for which there is no treatment and
no deﬁnitive premortem diagnosis. It has been closely
tied to athletes who participate in contact sports like
boxing, American football, soccer, professional wrestling,
a n dh o c k e y .A s i d ef r o mr e p e a t e dh e a dt r a u m a ,r i s kf a c t o r s
include presence of ApoE3 or ApoE4 allele, military service,
and old age. It is histologically identiﬁed by the presence
of tau-immunoreactive NFTs and NTs with some cases
having a TDP-43 proteinopathy or beta-amyloid plaques.
It has an insidious clinical presentation that begins with
cognitive and emotional disturbances and can progress to
Parkinsonian symptoms. The exact mechanism for CTE has
not been precisely deﬁned; however, research suggests it
is due to an ongoing metabolic and immunologic cascade
called immunoexcitotoxicity. Current research is attempting
toidentifyspeciﬁcbiomarkersalongwithmoresophisticated
imagingtechniquesforthediagnosisofCTE.Futureresearch
should also be centered around how to manage CTE as
suicide is a common fate for those battling the disease.
Further eﬀorts need to be made to educate players, coaches,
and administrators of all levels of athletics to make them
aware of the determents of mTBI and how to best protect
themselves. There must also be further investigations into
the possible link between CTE and motor neuron disease.
Establishing such a causal link may open new doors in ALS
research and hopefully lead to better treatments. Through
the continued eﬀorts of athletes, scientists, and physicians,
our knowledge of CTE will advance and allow for the
evolution of better diagnosis, treatment, and prevention.
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